{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T20:15:51Z","timestamp":1770754551703,"version":"3.50.0"},"reference-count":56,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T00:00:00Z","timestamp":1638748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Liver hepatocellular carcinoma (LIHC) is the third leading cause of cancer-related death and the sixth most common solid tumor worldwide. In the tumor microenvironment, the cross-talk between cancer cells, immune cells, and stromal cells exerts significant effects on neoplasia and tumor development and is modulated in part by chemokines. Chemokine (C-C motif) ligands (CCL) can directly target tumor cells and stromal cells, and they have been shown to regulate tumor cell proliferation, cancer stem-like cell properties, cancer invasiveness and metastasis, which directly and indirectly affect tumor immunity and influence cancer progression, therapy and patient outcomes. However, the prognostic values of chemokines CCL in LIHC have not been clarified.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> In this study, we comprehensively analyzed the relationship between transcriptional chemokines CCL and disease progression of LIHC using the ONCOMINE dataset, GEPIA, UALCAN, STRING, WebGestalt, GeneMANIA, TRRUST, DAVID 6.8, LinkedOmics, TIMER, GSCALite, and Open Targets. We validated the protein levels of chemokines CCL through western blot and immunohistochemistry.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> The transcriptional levels of <jats:italic>CCL5\/8\/11\/13\/15\/18\/20\/21\/25\/26\/27\/28<\/jats:italic> in LIHC tissues were significantly elevated while <jats:italic>CCL2\/3\/4\/14\/23\/24<\/jats:italic> were significantly reduced. A significant correlation was found between the expression of <jats:italic>CCL14\/25<\/jats:italic> and the pathological stage of LIHC patients. LIHC patients with low transcriptional levels of <jats:italic>CCL14\/21<\/jats:italic> were associated with a significantly poor prognosis. The functions of differentially expressed chemokines CCL were primarily related to the chemokine signaling pathway, cytokine\u2013cytokine receptor interactions, and TNF-\u03b1 signaling pathway. Our data suggested that RELA\/REL, NFKB1, STAT1\/3\/6, IRF3, SPI1, and JUN were key transcription factors for chemokines CCL. We found significant correlations among the expression of chemokines CCL and the infiltration of six types of immune cells (B cells, CD8<jats:sup>+<\/jats:sup> T cells, CD4<jats:sup>+<\/jats:sup> T cells, macrophages, neutrophils, and dendritic cells) and immune checkpoints (PD-1. PD-L1, and CTLA-4). The western blot and immunohistochemistry results showed that protein expression levels of CCL5 and CCL20 were upregulated in LIHC. CCL5 and CCL20 were significantly correlated with the clinical outcome of patients with LIHC, and could be negatively regulated by some drugs or small molecules.<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold> Our results may provide novel insights for the potential suitable targets of immunological therapy and prognostic biomarkers for LIHC.<\/jats:p>","DOI":"10.3389\/fcell.2021.748269","type":"journal-article","created":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T05:39:54Z","timestamp":1638769194000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Identification of Therapeutic Targets and Prognostic Biomarkers Among Chemokine (C-C Motif) Ligands in the Liver Hepatocellular Carcinoma Microenvironment"],"prefix":"10.3389","volume":"9","author":[{"given":"Zhongyi","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changchang","family":"Xing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pusen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueni","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,12,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.pharmthera.2016.09.011","article-title":"Chemokines, Cytokines and Exosomes Help Tumors to Shape Inflammatory Microenvironment","volume":"168","author":"Atretkhany","year":"2016","journal-title":"Pharmacol. Ther."},{"key":"B2","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/nrc1388","article-title":"Cancer and the Chemokine Network","volume":"4","author":"Balkwill","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"B3","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nrc2628","article-title":"Tumour Necrosis Factor and Cancer","volume":"9","author":"Balkwill","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"B4","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12943-019-0973-7","article-title":"Microvesicles and Chemokines in Tumor Microenvironment: Mediators of Intercellular Communications in Tumor Progression","volume":"18","author":"Bian","year":"2019","journal-title":"Mol. Cancer"},{"key":"B5","doi-asserted-by":"publisher","first-page":"C542","DOI":"10.1152\/ajpcell.00378.2019","article-title":"The CC and CXC Chemokines: Major Regulators of Tumor Progression and the Tumor Microenvironment","volume":"318","author":"Bikfalvi","year":"2020","journal-title":"Am. J. Physiol. Cel Physiol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1111\/febs.13627","article-title":"NFKB1: A Suppressor of Inflammation, Ageing and Cancer","volume":"283","author":"Cartwright","year":"2016","journal-title":"FEBS J."},{"key":"B7","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","article-title":"UALCAN: A portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses","volume":"19","author":"Chandrashekar","year":"2017","journal-title":"Neoplasia"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1126\/science.1071924","article-title":"TNF-R1 Signaling: A Beautiful Pathway","volume":"296","author":"Chen","year":"2002","journal-title":"Science"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1091\/mbc.02-02-0023","article-title":"Gene Expression Patterns in Human Liver Cancers","volume":"13","author":"Chen","year":"2002","journal-title":"Mol. Biol. Cel."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1158\/2326-6066.CIR-14-0160","article-title":"Chemokines in Cancer","volume":"2","author":"Chow","year":"2014","journal-title":"Cancer Immunol. Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and Cancer","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"},{"key":"B12","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.ccell.2019.05.004","article-title":"Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid Tumors","volume":"35","author":"Dangaj","year":"2019","journal-title":"Cancer Cell"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1111\/ajt.13749","article-title":"Functional Immune Anatomy of the Liver-As an Allograft","volume":"16","author":"Demetris","year":"2016","journal-title":"Am. J. Transpl."},{"key":"B14","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s00428-005-1264-9","article-title":"NF-kB in Development and Progression of Human Cancer","volume":"446","author":"Dolcet","year":"2005","journal-title":"Virchows Arch."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","article-title":"Hepatocellular Carcinoma","volume":"391","author":"Forner","year":"2018","journal-title":"Lancet"},{"key":"B16","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1053\/j.gastro.2018.09.051","article-title":"Targeted and Immune-Based Therapies for Hepatocellular Carcinoma","volume":"156","author":"Greten","year":"2019","journal-title":"Gastroenterology"},{"key":"B17","doi-asserted-by":"publisher","first-page":"D380","DOI":"10.1093\/nar\/gkx1013","article-title":"TRRUST V2: An Expanded Reference Database of Human and Mouse Transcriptional Regulatory Interactions","volume":"46","author":"Han","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"B18","doi-asserted-by":"publisher","first-page":"17582","DOI":"10.1073\/pnas.1409700111","article-title":"Acquisition of an Immunosuppressive Protumorigenic Macrophage Phenotype Depending on C-Jun Phosphorylation","volume":"111","author":"Hefetz-Sela","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"B19","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1158\/1078-0432.CCR-19-1868","article-title":"Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade","volume":"26","author":"House","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and Integrative Analysis of Large Gene Lists Using DAVID Bioinformatics Resources","volume":"4","author":"Huang","year":"2009","journal-title":"Nat. Protoc."},{"key":"B21","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.coi.2018.03.004","article-title":"Chemokines and Cancer: New Immune Checkpoints for Cancer Therapy","volume":"51","author":"Karin","year":"2018","journal-title":"Curr. Opin. Immunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1111\/j.1349-7006.2007.00606.x","article-title":"Chemokine Receptors in Cancer Metastasis and Cancer Cell-Derived Chemokines in Host Immune Response","volume":"98","author":"Koizumi","year":"2007","journal-title":"Cancer Sci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"D985","DOI":"10.1093\/nar\/gkw1055","article-title":"Open Targets: A Platform for Therapeutic Target Identification and Validation","volume":"45","author":"Koscielny","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"4556","DOI":"10.1158\/1078-0432.CCR-16-2821","article-title":"Phase I Trial of Intratumoral Injection of CCL21 Gene-Modified Dendritic Cells in Lung Cancer Elicits Tumor-specific Immune Responses and CD8(+) T-Cell Infiltration","volume":"23","author":"Lee","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","article-title":"TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells","volume":"77","author":"Li","year":"2017","journal-title":"Cancer Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"W199","DOI":"10.1093\/nar\/gkz401","article-title":"WebGestalt 2019: Gene Set Analysis Toolkit with Revamped UIs and APIs","volume":"47","author":"Liao","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"3771","DOI":"10.1093\/bioinformatics\/bty411","article-title":"GSCALite: A Web Server for Gene Set Cancer Analysis","volume":"34","author":"Liu","year":"2018","journal-title":"Bioinformatics"},{"key":"B28","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.canlet.2016.05.022","article-title":"Cancer-associated Fibroblasts Promote Hepatocellular Carcinoma Metastasis through Chemokine-Activated Hedgehog and TGF-Beta Pathways","volume":"379","author":"Liu","year":"2016","journal-title":"Cancer Lett."},{"key":"B29","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/hep.30134","article-title":"CCL15 Recruits Suppressive Monocytes to Facilitate Immune Escape and Disease Progression in Hepatocellular Carcinoma","volume":"69","author":"Liu","year":"2019","journal-title":"Hepatology"},{"key":"B30","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1093\/jnci\/djn134","article-title":"Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma","volume":"100","author":"Llovet","year":"2008","journal-title":"J. Natl. Cancer Inst."},{"key":"B31","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/s41571-018-0073-4","article-title":"Molecular Therapies and Precision Medicine for Hepatocellular Carcinoma","volume":"15","author":"Llovet","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.cytogfr.2014.09.003","article-title":"Negative Regulation of RelA Phosphorylation: Emerging Players and Their Roles in Cancer","volume":"26","author":"Lu","year":"2015","journal-title":"Cytokine Growth Factor. Rev."},{"key":"B33","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related Inflammation","volume":"454","author":"Mantovani","year":"2008","journal-title":"Nature"},{"key":"B34","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cytogfr.2009.11.007","article-title":"The Chemokine System in Cancer Biology and Therapy","volume":"21","author":"Mantovani","year":"2010","journal-title":"Cytokine Growth Factor. Rev."},{"key":"B35","doi-asserted-by":"publisher","first-page":"85","DOI":"10.2119\/molmed.2008.00110","article-title":"Genes Involved in Viral Carcinogenesis and Tumor Initiation in Hepatitis C Virus-Induced Hepatocellular Carcinoma","volume":"15","author":"Mas","year":"2009","journal-title":"Mol. Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"379","DOI":"10.3389\/fimmu.2019.00379","article-title":"Chemokines and Chemokine Receptors: New Targets for Cancer Immunotherapy","volume":"10","author":"Mollica","year":"2019","journal-title":"Front. Immunol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nri.2017.49","article-title":"Chemokines in the Cancer Microenvironment and Their Relevance in Cancer Immunotherapy","volume":"17","author":"Nagarsheth","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.semcancer.2019.05.002","article-title":"Toll-like Receptor-Induced Cytokines as Immunotherapeutic Targets in Cancers and Autoimmune Diseases","volume":"64","author":"Patra","year":"2020","journal-title":"Semin. Cancer Biol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s1476-5586(04)80047-2","article-title":"ONCOMINE: A Cancer Microarray Database and Integrated Data-Mining Platform","volume":"6","author":"Rhodes","year":"2004","journal-title":"Neoplasia"},{"key":"B40","doi-asserted-by":"publisher","first-page":"10202","DOI":"10.1158\/0008-5472.CAN-10-2607","article-title":"A Unique Metastasis Gene Signature Enables Prediction of Tumor Relapse in Early-Stage Hepatocellular Carcinoma Patients","volume":"70","author":"Roessler","year":"2010","journal-title":"Cancer Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1136\/gutjnl-2011-301116","article-title":"Adaptive Immunity Suppresses Formation and Progression of Diethylnitrosamine-Induced Liver Cancer","volume":"61","author":"Schneider","year":"2012","journal-title":"Gut"},{"key":"B42","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"B43","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","article-title":"STRING V11: Protein-Protein Association Networks with Increased Coverage, Supporting Functional Discovery in Genome-wide Experimental Datasets","volume":"47","author":"Szklarczyk","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"B44","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","article-title":"GEPIA: A Web Server for Cancer and normal Gene Expression Profiling and Interactive Analyses","volume":"45","author":"Tang","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2009.08.008","article-title":"Immune Tolerance: What Is Unique about the Liver","volume":"34","author":"Tiegs","year":"2010","journal-title":"J. Autoimmun."},{"key":"B46","doi-asserted-by":"publisher","first-page":"373","DOI":"10.18632\/oncotarget.10090610.18632\/oncotarget.170","article-title":"Mouse Models of Hepatocarcinogenesis: What Can We Learn for the Prevention of Human Hepatocellular Carcinoma?","volume":"1","author":"Vucur","year":"2010","journal-title":"Oncotarget"},{"key":"B47","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41392-020-0144-8","article-title":"PD-L1 Is a Direct Target of Cancer-FOXP3 in Pancreatic Ductal Adenocarcinoma (PDAC), and Combined Immunotherapy with Antibodies against PD-L1 and CCL5 Is Effective in the Treatment of PDAC","volume":"5","author":"Wang","year":"2020","journal-title":"Signal. Transduct Target. Ther."},{"key":"B48","doi-asserted-by":"publisher","first-page":"W214","DOI":"10.1093\/nar\/gkq537","article-title":"The GeneMANIA Prediction Server: Biological Network Integration for Gene Prioritization and Predicting Gene Function","volume":"38","author":"Warde-Farley","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"B49","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1002\/hep.21622","article-title":"Genome-wide Molecular Profiles of HCV-Induced Dysplasia and Hepatocellular Carcinoma","volume":"45","author":"Wurmbach","year":"2007","journal-title":"Hepatology"},{"key":"B50","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.ccr.2012.07.023","article-title":"TGF-beta-miR-34a-CCL22 Signaling-Induced Treg Cell Recruitment Promotes Venous Metastases of HBV-Positive Hepatocellular Carcinoma","volume":"22","author":"Yang","year":"2012","journal-title":"Cancer Cell"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.3892\/or.2017.5798","article-title":"CCL28 Promotes Breast Cancer Growth and Metastasis through MAPK-Mediated Cellular Anti-apoptosis and Pro-metastasis","volume":"38","author":"Yang","year":"2017","journal-title":"Oncol. Rep."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1002\/hep.31412","article-title":"Intratumoral Gammadelta T-Cell Infiltrates, Chemokine (C-C Motif) Ligand 4\/Chemokine (C-C Motif) Ligand 5 Protein Expression and Survival in Patients with Hepatocellular Carcinoma","volume":"73","author":"Zhao","year":"2021","journal-title":"Hepatology"},{"key":"B53","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/s41419-019-1966-6","article-title":"CCL14 Serves as a Novel Prognostic Factor and Tumor Suppressor of HCC by Modulating Cell Cycle and Promoting Apoptosis","volume":"10","author":"Zhu","year":"2019","journal-title":"Cell Death Dis"},{"key":"B54","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3892\/or.2017.6069","article-title":"CCL2\/CCR2 axis Induces Hepatocellular Carcinoma Invasion and Epithelial-Mesenchymal Transition In Vitro through Activation of the Hedgehog Pathway","volume":"39","author":"Zhuang","year":"2018","journal-title":"Oncol. Rep."},{"key":"B55","doi-asserted-by":"publisher","first-page":"509","DOI":"10.2174\/187152811798104890","article-title":"Modification of Chemokine Pathways and Immune Cell Infiltration as a Novel Therapeutic Approach in Liver Inflammation and Fibrosis","volume":"10","author":"Zimmermann","year":"2011","journal-title":"Inflamm. Allergy Drug Targets"},{"key":"B56","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/s1074-7613(00)80165-x","article-title":"Chemokines: A New Classification System and Their Role in Immunity","volume":"12","author":"Zlotnik","year":"2000","journal-title":"Immunity"}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2021.748269\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T05:39:57Z","timestamp":1638769197000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2021.748269\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,6]]},"references-count":56,"alternative-id":["10.3389\/fcell.2021.748269"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2021.748269","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,6]]},"article-number":"748269"}}